Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic stapes footplates in connection with measles virus positivity

Laryngoscope

Volumn 116, Issue 8, 2006, Pages 1427-1433

  Karosi, Tamás ^a   Jókay, István ^a   Kónya, József ^a   Szabó, László Z ^b   Pytel, József ^c   Jóri, József ^d   Szalmás, Anita ^a   Sziklai, István ^a,e  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b National Health Center   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

^e NONE   (Hungary)

Author keywords

Measles virus; Osteoprotegerin; Otosclerosis; RT PCR; Stapes fixation; TNF alpha

Indexed keywords

MESSENGER RNA; NUCLEIC ACID; NUCLEOPROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ADULT; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEASLES VIRUS; OSTEOCLAST; OTOSCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPES; VIRUS INFECTION;

ADULT; CARRIER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MEASLES; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOPROTEGERIN; OTOSCLEROSIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; STAPES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746850628     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000225928.35838.e5     Document Type: Article

References (15)

1. Chole RA, McKenna M. Pathophysiology of otosclerosis. Otol Neurotol 2001;22:249-257.
2. Iyer V, Gristwood H. Histopathology of the stapes in otosclerosis. Pathology 1984;16:30-38.
3. Karosi T, Kónya J, Petkó MZ, et al. Co-detection of measles virus and TNF-alpha mRNA in otosclerotic stapes footplates. Laryngoscope 2005;115:121-129.
4. Sziklai I. Human otosclerotic bone-derived peptide decreases the gain of the electromotility in isolated outer hair cells. Hear Res 1996;95:100-107.
5. Nakatsuka K, Nishizawa Y, Ralston SH. Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res 2003;18:1381-1385.
6. Boyce BF, Li P, Yao Z, et al. TNF-alpha and pathologic bone resorption. Keio J Med 2005;54:127-131.
7. Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodelling. Cytokine Growth Factor Rev 2004;15:457-475.
8. Wittrant Y, Theoleyre S, Chipoy C, et al. RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta 2004;1704:49-57.
9. McKenna MJ, Mills BG. Ultrastructural and immunohistochemical evidence of measles virus in active otosclerosis. Acta Otolaryngol (Stockh) Suppl 1990;470:130-140.
10. Niedermeyer HP, Arnold W, Neubert WJ, Sedlmeier R. Persistent measles virus infection as a possible cause of otosclerosis: state of art. Ear Nose Throat J 2000;79:552-554, 556, 558.
11. Karosi T, Kónya JZ, Szabó L, Sziklai I. Measles virus prevalence in otosclerotic stapes footplate samples. Otol Neurotol 2004;25:451-456.
12. Zehnder AF, Kristiansen AG, Adams JC, Merchant SN, McKenna MJ. Osteoprotegerin in the inner ear may inhibit bone remodelling in the otic capsule. Laryngoscope 2005;115:172-177.
13. Zehnder AF, Kristiansen AG, Adams JC, Kujawa SG, Merchant SN, McKenna MJ. Osteoprotegerin knockout mice demonstrate abnormal bone remodeling of the otic capsule and progressive hearing loss. Laryngoscope 2006;116:201-206.
14. Hamzei M, Ventriglia G, Hagnia M, et al. Osteoclast stimulating and differentiating factors in human cholesteatoma. Laryngoscope 2003;113:436-442.
15. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM. Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope 2002;112:1627-1634.